TEVA Vincristine Sulfate is an antineoplastic, prescription-only intravenous solution standardized at 1 mg/mL. Each mL contains vincristine sulfate with mannitol and parabens in water for injection, with pH adjusted using sodium hydroxide and/or sulfuric acid. The product carries DIN 02143305 and is available in 1 mL and 5 mL vial formats to suit clinical inventory needs. Designed for IV administration by qualified professionals, it provides consistent concentration and clearly listed preservatives for formulary transparency.